Stress Hyperglycemia. Potential Role of Incretin Analogs

Completed

• Conditions: Hyperglycemia; Critical Illness

• Registration Number: NCT01087372
• Lead Sponsor: Hospital Universitari Son Dureta

Brief Summary

This is a prospective observational study to examine the levels of glucoregulatory hormones, with special focus on incretins levels, in critically ill patients with stress hyperglycemia.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2010-03-11
• Study First Submitted QC: 2010-03-15
• Study First Posted: 2010-03-16
• Primary Completion: 2010-04
• Study Completion: 2010-04
• Status Verified: 2010-06
• Last Update Submitted: 2010-06-07
• Last Update Posted: 2010-06-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Age > 18 years
• Emergent ICU admission
• Written informed consent from patient or relative.

Exclusion Criteria

• Previously known type I or type II diabetes.
• Patients who received insulin or oral antidiabetic agents before ICU admission.
• Malignancies.
• Scheduled surgery
• Patients receiving enteral or parenteral nutrition.
• Inability to obtain informed consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incretins plasmatic levels	28 days	28 days and ICU mortality

Secondary Outcome Measures

Name	Time	Method
glucagon	28 days	28 days and ICU mortality
insulin	28 days	28 days and ICU mortality
cortisol	28 days	28 days and ICU mortality
HOMA index	28 days	28 days and ICU mortality

Trial Locations

Locations (1)

Hospital Universitari Son Dureta. Intensive Care Unit; 🇪🇸 Palma de Mallorca, Illes Balears, Spain